Skip to main navigation Skip to search Skip to main content

Type 2 biomarkers and airway hyper-responsiveness disconnect in patients with uncontrolled severe asthma taking benralizumab or dupilumab

Research output: Contribution to journal › Letter › peer-review

37 Downloads (Pure)
Original languageEnglish
Pages (from-to)448-449
Number of pages2
JournalAnnals of Allergy, Asthma and Immunology
Volume135
Issue number4
Early online date26 Jul 2025
DOIs
Publication statusPublished - Oct 2025

Cite this